13 of 25
BACKNEXT
13. Abbott Laboratories
Ticker: ABT

Rob McIver
Jensen Fund

Rob McIver is choosy. Each of the 30 stocks that make it into the $3 billion Jensen Fund must post a return on equity of more than 15% for each of the past 10 years. One slip in profits and the stock is out. The idea is that companies with consistent returns have long-term advantages like pricing power and smarter managers -- and thus make shareholders more money.

The approach has produced outstanding results: The Jensen fund beat the S&P 500 by an average 3.4 percentage points a year for the past decade. McIver calls Abbott Laboratories a stock for the long run. The pharmaceutical company has great products like Humira, the hit rheumatoid arthritis drug; a return on equity of 28%; and a huge presence in emerging markets. The stock boasts a 3.5% dividend yield and is trading at just 10 times expected earnings.

"It's a very powerful story," says McIver.

--S.C.

NEXT: Petrobras

Last updated June 18 2010: 12:58 PM ET
5 best places to retire With prices falling, now could be the time to score a sweet second home. More
You can bet on the recovery T. Rowe Price's Brian Rogers sees plenty of value in stocks for long-term investors. More
The senator who wants to save your retirement While his better-known colleagues wrestle over fixing the financial system, Herb Kohl is working to guarantee your golden years. More